↓ Skip to main content

Dove Medical Press

Glucarpidase for Treating Adults with Delayed Methotrexate Elimination Due to Impaired Renal Function: An Economic Simulation Analysis

Overview of attention for article published in ClinicoEconomics and Outcomes Research: CEOR, March 2023
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#11 of 524)
  • High Attention Score compared to outputs of the same age (98th percentile)
  • High Attention Score compared to outputs of the same age and source (88th percentile)

Mentioned by

news
20 news outlets
twitter
4 X users

Citations

dimensions_citation
1 Dimensions

Readers on

mendeley
4 Mendeley
Title
Glucarpidase for Treating Adults with Delayed Methotrexate Elimination Due to Impaired Renal Function: An Economic Simulation Analysis
Published in
ClinicoEconomics and Outcomes Research: CEOR, March 2023
DOI 10.2147/ceor.s397154
Pubmed ID
Authors

Jaya Kala, Rebecca Nelson, Christopher Drudge, Allen Zhou, Suzanne Ward, Megan Bourque

X Demographics

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 4 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 4 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 2 50%
Unspecified 1 25%
Lecturer 1 25%
Readers by discipline Count As %
Medicine and Dentistry 2 50%
Biochemistry, Genetics and Molecular Biology 1 25%
Unspecified 1 25%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 152. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 22 March 2023.
All research outputs
#271,882
of 25,540,105 outputs
Outputs from ClinicoEconomics and Outcomes Research: CEOR
#11
of 524 outputs
Outputs of similar age
#6,664
of 423,545 outputs
Outputs of similar age from ClinicoEconomics and Outcomes Research: CEOR
#1
of 9 outputs
Altmetric has tracked 25,540,105 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 98th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 524 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 12.0. This one has done particularly well, scoring higher than 97% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 423,545 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 9 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them